Overview

NA-Selank Amidate is the most structurally optimized form of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), incorporating two key chemical modifications: N-terminal acetylation and C-terminal amidation. The parent compound Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences by extending the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with a stabilizing Pro-Gly-Pro glyproline sequence. While N-Acetyl Selank addresses aminopeptidase vulnerability at the N-terminus, the additional C-terminal amidation in NA-Selank Amidate protects against carboxypeptidase degradation, effectively shielding both ends of the peptide from the primary exopeptidase attack points. This dual modification significantly extends biological half-life and may enhance lipophilicity for improved blood-brain barrier penetration and intranasal absorption.

The pharmacological profile of NA-Selank Amidate mirrors and potentially amplifies that of its parent compounds, encompassing three interconnected domains. Its anxiolytic activity is mediated through positive allosteric modulation of GABA-A receptors, enhancement of serotonergic neurotransmission, and robust upregulation of brain-derived neurotrophic factor (BDNF) in the hippocampus and prefrontal cortex — producing anxiolysis without the sedation, cognitive impairment, or dependence liability associated with benzodiazepines. The nootropic effects include improved memory consolidation, enhanced attention, and facilitated learning through BDNF-dependent neuroplasticity and stabilization of enkephalin metabolism. The immunomodulatory dimension, derived from the tuftsin core, involves stimulation of IL-6 expression, modulation of T-helper cell balance, and enhanced innate immune function — uniquely bridging the neuroimmune axis.

NA-Selank Amidate is typically administered intranasally at doses of 200–500 mcg per nostril, 1–3 times daily, with effects generally noted within 15–30 minutes. It is frequently combined with NA-Semax Amidate in comprehensive nootropic protocols, leveraging complementary mechanisms: Selank's calming GABAergic/anxiolytic profile balances Semax's stimulatory dopaminergic and cognitive-enhancing effects. This pairing is considered one of the most well-characterized synergistic peptide combinations in the nootropic community. Side effects are minimal and typically limited to mild nasal irritation. NA-Selank Amidate represents the current state-of-the-art in Selank peptide engineering, offering the greatest stability and potency among the Selank family of compounds.

Mechanism of Action

Dual Stability Modifications

NA-Selank Amidate represents the most metabolically stabilized form of the Selank heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro). It incorporates two protective modifications:

1. N-terminal acetylation (NA) — blocks aminopeptidase cleavage at the Thr1 position
2. C-terminal amidation — replaces the terminal carboxyl group with an amide, preventing carboxypeptidase degradation and improving membrane interactions

These modifications act synergistically to extend the peptide's plasma half-life and CNS residence time, allowing lower dosing frequency and potentially improved intranasal bioavailability.

Anxiolytic Mechanism: GABAergic Enhancement

Like parent Selank, NA-Selank Amidate enhances GABAergic neurotransmission in the amygdala, hippocampus, and prefrontal cortex. It allosterically increases GABA-A receptor sensitivity, augmenting inhibitory chloride currents in anxiety-processing circuits. This mechanism produces anxiolysis comparable to benzodiazepines in behavioral assays (elevated plus maze, light-dark box) without producing sedation, motor impairment, or withdrawal symptoms. Transcriptomic analysis shows upregulation of specific GABA-A receptor subunit genes (alpha, gamma) in hippocampal tissue.

Nootropic Effects: BDNF & Synaptic Plasticity

NA-Selank Amidate increases BDNF expression and secretion in hippocampal and cortical neurons. BDNF/TrkB activation initiates the Ras/MEK/ERK, PI3K/Akt, and PLCγ/CaMKII cascades that underpin long-term potentiation (LTP), dendritic spine growth, and adult hippocampal neurogenesis. These molecular effects translate to improved spatial learning, associative memory, and attentional performance in preclinical behavioral paradigms.

Serotonergic & Enkephalinergic Modulation

The peptide modulates serotonin turnover by influencing tryptophan hydroxylase 2 (TPH2), SERT/SLC6A4 expression, and 5-HT1A receptor sensitivity. It also affects the enkephalin system, with gene expression studies showing upregulation of proenkephalin in select brain regions. This opioidergic modulation may contribute to stress resilience and emotional regulation without producing euphoria or dependence.

Immunomodulatory Properties

The tuftsin core sequence (Thr-Lys-Pro-Arg) activates NRP1 and tuftsin receptors on monocytes, macrophages, and NK cells. This enhances phagocytic capacity, antigen presentation, and balanced cytokine production. NA-Selank Amidate normalizes stress-induced immune suppression by restoring IL-2, IL-10, and IFN-gamma levels while reducing excessive IL-6 and TNF-alpha production.

Reconstitution Calculator

Safety Profile

Side effects are infrequent and mild, potentially including nasal irritation, headaches, and transient drowsiness or restlessness. It should be avoided during pregnancy and with CNS depressants, and caution is warranted for those with active cancer. This compound lacks specific human studies and FDA approval, and carries a theoretical risk of immunogenicity.

Pharmacokinetic Profile